38 related articles for article (PubMed ID: 27399327)
1. Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score-matching Analysis.
Pan T; Xie QK; Lv N; Li XS; Mu LW; Wu PH; Zhao M
Radiology; 2017 Jan; 282(1):259-270. PubMed ID: 27399327
[TBL] [Abstract][Full Text] [Related]
2. Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience.
Kalra N; Kang M; Bhatia A; Duseja AK; Dhiman RK; Arya VK; Rajwanshi A; Chawla YK; Khandelwal N
Indian J Radiol Imaging; 2013 Apr; 23(2):139-44. PubMed ID: 24082478
[TBL] [Abstract][Full Text] [Related]
3. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.
Biederman DM; Titano JJ; Bishay VL; Durrani RJ; Dayan E; Tabori N; Patel RS; Nowakowski FS; Fischman AM; Kim E
Radiology; 2017 Jun; 283(3):895-905. PubMed ID: 27930089
[TBL] [Abstract][Full Text] [Related]
4. Image-Guided Ablation Therapies for Extrahepatic Metastases from Hepatocellular Carcinoma: A Review.
Umakoshi N; Matsui Y; Tomita K; Uka M; Kawabata T; Iguchi T; Hiraki T
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509326
[TBL] [Abstract][Full Text] [Related]
5. Local Treatment of Hepatocellular Carcinoma with Oligometastases: A Systematic Review and Meta-Analysis.
Kim S; Lee J; Rim CH
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444577
[TBL] [Abstract][Full Text] [Related]
6. Chemo-immunoablation of solid tumors: A new concept in tumor ablation.
Meng L; Wei Y; Xiao Y
Front Immunol; 2022; 13():1057535. PubMed ID: 36713427
[TBL] [Abstract][Full Text] [Related]
7. Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments.
Iezzi R; Gangi A; Posa A; Pua U; Liang P; Santos E; Kurup AN; Tanzilli A; Tenore L; De Leoni D; Filippiadis D; Giuliante F; Valentini V; Gasbarrini A; Goldberg SN; Meijerink M; Manfredi R; Kelekis A; Colosimo C; Madoff DC
Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612304
[TBL] [Abstract][Full Text] [Related]
8. Role of Local Treatment for Oligometastasis: A Comparability-Based Meta-Analysis.
Rim CH; Cho WK; Lee JH; Kim YS; Suh YG; Kim KH; Chie EK; Ahn YC;
Cancer Res Treat; 2022 Oct; 54(4):953-969. PubMed ID: 35989655
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles promotes liver metastasis of lung cancer by ALAHM increasing hepatocellular secretion of HGF.
Jiang C; Li X; Sun B; Zhang N; Li J; Yue S; Hu X
iScience; 2022 Mar; 25(3):103984. PubMed ID: 35281743
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma.
Chen X; Lu Y; Shi X; Han G; Zhao J; Gao Y; Wang X
Front Oncol; 2022; 12():835957. PubMed ID: 35223515
[TBL] [Abstract][Full Text] [Related]
11. Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou Recommendations.
Chen QF; Li W; Yu SC; Chou YH; Rhim H; Yang X; Shen L; Dong A; Huang T; Huang J; Zhang F; Fan W; Zhao M; Gu Y; Huang Z; Zuo M; Zhai B; Xiao Y; Kuang M; Li J; Han J; Song W; Ma J; Wu P
Front Oncol; 2021; 11():621834. PubMed ID: 34277397
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and safety of percutaneous computed tomography guided radiofrequency ablation of lymph nodes in oligometastatic patients: a single center's experience.
Filippiadis D; Charalampopoulos G; Tsochatzis A; Reppas L; Mazioti A; Kelekis A; Kelekis N
Br J Radiol; 2021 May; 94(1121):20200445. PubMed ID: 33756082
[TBL] [Abstract][Full Text] [Related]
13. Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review.
Rim CH; Shin IS; Park S; Lee HY
NPJ Precis Oncol; 2021 Jan; 5(1):2. PubMed ID: 33479481
[TBL] [Abstract][Full Text] [Related]
14. Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study.
Lyu N; Kong Y; Li X; Mu L; Deng H; Chen H; He M; Lai J; Li J; Tang H; Lin Y; Zhao M
Front Oncol; 2020; 10():580241. PubMed ID: 33163408
[No Abstract] [Full Text] [Related]
15. The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study.
Chen L; Sun T; Chen S; Ren Y; Yang F; Zheng C
World J Surg Oncol; 2020 Jun; 18(1):119. PubMed ID: 32487104
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space.
Heinze C; Omari J; Manig M; Hass P; Venerito M; Damm R; Jargiełło T; Ricke J; Powerski M; Pech M
J Contemp Brachytherapy; 2019 Oct; 11(5):436-442. PubMed ID: 31749852
[TBL] [Abstract][Full Text] [Related]
18. Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis.
Yuan WH; Li AF; Hsu HC; Hu YS; Lee RC
PLoS One; 2019; 14(11):e0225043. PubMed ID: 31710641
[TBL] [Abstract][Full Text] [Related]
19. Tree-based classification system incorporating the HVTT-PVTT score for personalized management of hepatocellular carcinoma patients with macroscopic vascular invasion.
Cao F; Shen L; Qi H; Xie L; Song Z; Chen S; Fan W
Aging (Albany NY); 2019 Nov; 11(21):9544-9555. PubMed ID: 31682230
[TBL] [Abstract][Full Text] [Related]
20. A Noninvasive Prediction Nomogram for Lymph Node Metastasis of Hepatocellular Carcinoma Based on Serum Long Noncoding RNAs.
Ma J; Zhang L; Bian HR; Lu ZG; Zhu L; Yang P; Zeng ZC; Xiang ZL
Biomed Res Int; 2019; 2019():1710670. PubMed ID: 31355249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
